What is Zacks Research's Forecast for Zoetis Q2 Earnings?

Zoetis Inc. (NYSE:ZTS - Free Report) - Equities research analysts at Zacks Research cut their Q2 2025 earnings estimates for Zoetis in a report released on Monday, November 25th. Zacks Research analyst E. Bagri now expects that the company will post earnings per share of $1.66 for the quarter, down from their previous forecast of $1.68. The consensus estimate for Zoetis' current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Zoetis' Q3 2025 earnings at $1.65 EPS, FY2025 earnings at $6.37 EPS, Q2 2026 earnings at $1.76 EPS and FY2026 earnings at $6.91 EPS.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. During the same period in the prior year, the firm earned $1.36 EPS. The firm's revenue was up 11.6% on a year-over-year basis.

Other equities analysts have also issued reports about the stock. Stifel Nicolaus raised their price target on shares of Zoetis from $200.00 to $210.00 and gave the stock a "buy" rating in a research report on Wednesday, September 18th. Piper Sandler boosted their target price on shares of Zoetis from $195.00 to $210.00 and gave the company an "overweight" rating in a research report on Wednesday, August 14th. Argus raised Zoetis to a "strong-buy" rating in a research report on Friday, August 9th. BTIG Research boosted their price objective on Zoetis from $220.00 to $225.00 and gave the company a "buy" rating in a report on Monday, August 12th. Finally, JPMorgan Chase & Co. raised their target price on Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Zoetis has a consensus rating of "Buy" and an average price target of $221.44.

Zoetis Stock Performance

Shares of NYSE:ZTS traded up $1.04 during trading on Thursday, hitting $176.74. The stock had a trading volume of 2,315,768 shares, compared to its average volume of 2,968,865. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis has a 12-month low of $144.80 and a 12-month high of $201.92. The stock has a market capitalization of $79.74 billion, a price-to-earnings ratio of 33.22, a price-to-earnings-growth ratio of 2.70 and a beta of 0.90. The stock has a 50-day simple moving average of $184.51 and a two-hundred day simple moving average of $180.81.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ZTS. Darwin Wealth Management LLC acquired a new position in Zoetis in the third quarter valued at about $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis in the 3rd quarter valued at approximately $33,000. Capital Performance Advisors LLP acquired a new position in shares of Zoetis in the 3rd quarter worth approximately $33,000. Dunhill Financial LLC boosted its position in shares of Zoetis by 80.6% during the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after purchasing an additional 75 shares during the period. Finally, Quarry LP boosted its position in shares of Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company's stock worth $36,000 after purchasing an additional 153 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Thursday, October 31st. Zoetis's payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.